VA study of antipsychotic-related diabetes
Executive Summary
Department of Veteran's Affairs study "Antipsychotic Induced Diabetes in Veteran Schizophrenic Patients" will be submitted to the Journal of the American Medical Association for publication at the beginning of September (1"The Pink Sheet" April 21, 2003, p. 11). The study, scheduled to be presented at the International Conference on Therapeutic Risk in Philadelphia Aug. 24, found that Lilly's Zyprexa, Johnson & Johnson's Risperdal and AstraZeneca's Seroquel are associated with similar rates of metabolic complications...
You may also be interested in...
Schizophrenia Drugs And Diabetes: VA Data On Causal Link Expected In June
The Department of Veterans Affairs expects to have data from a study on the relationship between atypical antipsychotics and diabetes in late June
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.